Phase II Trial of Arsenic Trioxide and Dose-Escalated Cholecalciferol in Myelodysplastic Syndrome.

Trial Profile

Phase II Trial of Arsenic Trioxide and Dose-Escalated Cholecalciferol in Myelodysplastic Syndrome.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 23 Jan 2017

At a glance

  • Drugs Arsenic trioxide (Primary) ; Colecalciferol
  • Indications Myelodysplastic syndromes
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Jul 2012 Actual end date (1 May 2010) added as reported by ClinicalTrials.gov.
    • 01 May 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 13 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top